Foxo Technologies Inc
FOXO0.151USD
-0.005-3.46%
Market hours （ET）Quotes delayed by 15 min
51.63KMarket Cap
LossP/E TTM
More Details of Foxo Technologies Inc Company
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Company Info
Ticker SymbolFOXO
Company nameFoxo Technologies Inc
IPO dateDec 11, 2020
CEOMr. Seamus Lagan
Number of employees- -
Security typeOrdinary Share
Fiscal year-endDec 11
Address477 South Rosemary Avenue
CityWEST PALM BEACH
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code33401
Phone16128000059
Websitehttp://delwinds.com/
Ticker SymbolFOXO
IPO dateDec 11, 2020
CEOMr. Seamus Lagan
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
167.00
--
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
167.00
--
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Rennova Health, Inc.
0.96%
Clearthink Capital Partners LLC
0.56%
Kr8 ai Inc
0.22%
UBS Financial Services, Inc.
0.14%
Geode Capital Management, L.L.C.
0.14%
Other
97.97%
Shareholders
Shareholders
Proportion
Rennova Health, Inc.
0.96%
Clearthink Capital Partners LLC
0.56%
Kr8 ai Inc
0.22%
UBS Financial Services, Inc.
0.14%
Geode Capital Management, L.L.C.
0.14%
Other
97.97%
Shareholder Types
Shareholders
Proportion
Corporation
1.75%
Investment Advisor
0.21%
Investment Advisor/Hedge Fund
0.17%
Research Firm
0.05%
Hedge Fund
0.03%
Other
97.80%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
42
117.55K
2.20%
-40.11K
2025Q1
44
283.42K
16.93%
-74.76K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
2023Q2
124
2.96M
79.90%
-804.39K
2023Q1
129
1.99M
69.67%
-1.77M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Rennova Health, Inc.
102.36K
0.96%
-1.00
-0.00%
May 21, 2025
Clearthink Capital Partners LLC
60.00K
0.56%
+60.00K
--
Dec 01, 2023
Kr8 ai Inc
23.70K
0.22%
-1.00
-0.00%
May 21, 2025
UBS Financial Services, Inc.
15.02K
0.14%
+1.03K
+7.33%
Mar 31, 2025
Geode Capital Management, L.L.C.
14.40K
0.14%
+10.16K
+239.24%
Mar 31, 2025
SBI Securities Co., Ltd.
5.10K
0.05%
+1.17K
+29.67%
Mar 31, 2025
Corbin Capital Partners, L.P.
2.75K
0.03%
--
--
Dec 31, 2024
Capital Investment Advisory Services, LLC
2.50K
0.02%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
2.42K
0.02%
--
--
Mar 31, 2025
State Street Global Advisors (US)
2.00K
0.02%
--
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Date
Type
Ratio
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
